United Services Automobile Association’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-7,398
Closed -$412K 1834
2019
Q2
$412K Hold
7,398
﹤0.01% 1707
2019
Q1
$374K Hold
7,398
﹤0.01% 1772
2018
Q4
$298K Buy
7,398
+845
+13% +$43.5K ﹤0.01% 1826
2018
Q3
$454K Sell
6,553
-4,740
-42% -$359K ﹤0.01% 1727
2018
Q2
$854K Hold
11,293
﹤0.01% 1448
2018
Q1
$595K Buy
11,293
+1,523
+16% +$88.6K ﹤0.01% 1627
2017
Q4
$522K Hold
9,770
﹤0.01% 1383
2017
Q3
$583K Buy
+9,770
New +$591K ﹤0.01% 1313

Other funds holding EGRX

United Services Automobile Association's EGRX Position: Q3 2019 in Review

United Services Automobile Association sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q3 2019, closing a stake of 7,398 shares — an estimated $412K sold.

United Services Automobile Association first reported a position in EGRX in Q3 2017 and held it in 8 quarters. The position peaked at $854K in Q2 2018. 183 funds tracked by Wall St. Rank hold EGRX as of Q3 2019.

  • United Services Automobile Association reported no remaining Eagle Pharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
  • United Services Automobile Association sold 7,398 Eagle Pharmaceuticals, Inc. shares in Q3 2019, an estimated $412K.
  • United Services Automobile Association first reported a position in Eagle Pharmaceuticals, Inc. in Q3 2017 and held it in 8 quarters.
  • United Services Automobile Association's Eagle Pharmaceuticals, Inc. position peaked at $854K in Q2 2018.
  • 183 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q3 2019.

Based on United Services Automobile Association's 13F filing for Q3 2019, filed 13 Nov 2019.